Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash & Current Investments (2022 - 2025)

Historic Cash & Current Investments for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $892.4 million.

  • Immunocore Holdings' Cash & Current Investments fell 99.07% to $892.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $892.4 million, marking a year-over-year decrease of 99.07%. This contributed to the annual value of $820.4 million for FY2024, which is 8534.29% up from last year.
  • As of Q3 2025, Immunocore Holdings' Cash & Current Investments stood at $892.4 million, which was down 99.07% from $882.8 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Cash & Current Investments ranged from a high of $901.3 million in Q3 2024 and a low of $321.1 million during Q4 2021
  • For the 5-year period, Immunocore Holdings' Cash & Current Investments averaged around $617.0 million, with its median value being $444.5 million (2023).
  • Per our database at Business Quant, Immunocore Holdings' Cash & Current Investments surged by 10339.52% in 2024 and then tumbled by 99.07% in 2025.
  • Quarter analysis of 5 years shows Immunocore Holdings' Cash & Current Investments stood at $321.1 million in 2021, then increased by 25.32% to $402.5 million in 2022, then rose by 9.98% to $442.6 million in 2023, then surged by 85.34% to $820.4 million in 2024, then rose by 8.77% to $892.4 million in 2025.
  • Its last three reported values are $892.4 million in Q3 2025, $882.8 million for Q2 2025, and $837.0 million during Q1 2025.